Form:	Prostate Upgrading: Prostatectomy v1.1

CDE ID	CDE Description
* 2777	Site participant ID (Go To: 422)
* 422	EDRN Site ID (Go To: 423)
* 423	EDRN Protocol ID (Go To: 929)
* 929	EDRN Staff ID of the person who collected the data: (Go To: 578)
* 578	Age at specimen collection (Go To: 1322)
* 1322	Hispanic or Latino (Are you Hispanic or Latino?) (Go To: 1315)
	Permissible Values (value): No (0)
	Yes (1)
	Refused (88)
	Unknown (99)
* 1315	Race (What is your race? Check all that apply.) (Go To: 1569)
	Permissible Values (value): White (1)
	Black or African-American (2)
	American Indian or Alaska Native (3)
	Asian (4)
	Native Hawaiian or other Pacific Islander (7)
	Refused (88)
	Other (95)
	Other, specify: (97) (Go To: 1294)
	Unknown (99)
* 1294	Race (Other, specify) (Go To: 1569)
1569	How many of the participant´s living or deceased first or second-degree blood relatives have been diagnosed with prostate cancer? (Go To: 774)
* 774	Date of surgery (MM/DD/YYYY): (Go To: 2610)
2610	Prostate T-Stage, Pathologic: (Go To: 2611)
	Permissible Values (value): pT0 (2)
	pT1a (10)
	pT1b (11)
	pT1c (12)
	pT2 (13)
	pT2a (14)
	pT2b (15)
	pT3 (16)
	pT3b (18)
	pT2c (27)
	pT3a (30)
	pT3b (31)
	pT3c (32)
	pT4 (34)
	pT4a (35)
2611	Prostate N-Stage, Pathologic: (Go To: 2612)
	Permissible Values (value): pNX (1)
	pN0 (2)
	pN1 (7)
2612	Prostate M-Stage, Pathologic: (Go To: 2618)
	Permissible Values (value): MX (1)
	M0 (2)
	M1 (3)
	M1a (4)
	M1b (5)
	M1c (6)
2618	Margin status (presence of cancer at margin): (Go To: 2619)
	Permissible Values (value): Positive (1)
	Negative (2)
	Uncertain (borderline case) (3)
	N/A (98)
	Unknown (99)
2619	Site(s) of positive margin(s): (Go To: 1687)
	Permissible Values (value): Anterior right (1)
	Anterior left (2)
	Posterior right (3)
	Posterior left (4)
	Unknown (99)
1687	Total number of lymph nodes examined : (Go To: 2613)
2613	Number of lymph nodes with cancer: (Go To: 2628)
2628	Seminal vesicle invasion? (Go To: 2626)
	Permissible Values (value): No (0)
	Yes (1) (Go To: 2629)
	Unknown (99)
2629	Seminal vesicle invasion site: (Go To: 2626)
	Permissible Values (value): Right (1)
	Left (2)
	Both (3)
	Other (95)
	Unknown (99)
2626	Extraprostatic extension (EPE) status: (Go To: 1591)
	Permissible Values (value): Positive (1) (Go To: 2627)
	Negative (2)
	Uncertain (borderline case) (3) (Go To: 2627)
	Unknown (99)
2627	Extraprostatic extension (EPE) site(s): (Go To: 1591)
	Permissible Values (value): Anterior right (1)
	Anterior left (2)
	Posterior right (3)
	Posterior left (4)
1591	Perineural invasion: (Go To: 3404)
	Permissible Values (value): Present (1)
	Absent (2)
	Unknown (99)
3404	Percent of cancer in organ: (Go To: 2614)
2614	Estimated tumor volume (cc): (Go To: 2722)
2722	Prostate volume (cc): (Go To: 1589)
1589	Primary Gleason grade: (Go To: 1590)
1590	Secondary Gleason grade: (Go To: 1696)
1696	Tertiary Gleason Pattern: (Go To: 3405)
3405	Percentage of tumor tissue with Gleason Pattern 4: (Go To: 1097)
1097	Comments (do not include any participant identifiers) (Go To: 2749)
2749	Coordinating center data comments: (Go To: End of Form)